NanoViricides, Inc.
NNVC
$1.13
-$0.01-0.88%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.82M | 3.61M | 4.04M | 4.31M | 4.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.39M | 8.22M | 9.59M | 9.87M | 9.53M |
| Operating Income | -8.39M | -8.22M | -9.59M | -9.87M | -9.53M |
| Income Before Tax | -8.32M | -8.13M | -9.47M | -9.73M | -9.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.32 | -8.13 | -9.47 | -9.73 | -9.36 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.32M | -8.13M | -9.47M | -9.73M | -9.36M |
| EBIT | -8.39M | -8.22M | -9.59M | -9.87M | -9.53M |
| EBITDA | -7.78M | -7.54M | -8.85M | -9.09M | -8.75M |
| EPS Basic | -0.48 | -0.51 | -0.63 | -0.70 | -0.72 |
| Normalized Basic EPS | -0.30 | -0.32 | -0.40 | -0.44 | -0.45 |
| EPS Diluted | -0.48 | -0.51 | -0.63 | -0.70 | -0.72 |
| Normalized Diluted EPS | -0.30 | -0.32 | -0.40 | -0.44 | -0.45 |
| Average Basic Shares Outstanding | 69.14M | 63.86M | 60.49M | 56.55M | 52.31M |
| Average Diluted Shares Outstanding | 69.14M | 63.86M | 60.49M | 56.55M | 52.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |